IFOSFAMIDE (eye FOS fa mide) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat testicular cancer and other cancers.
|
IFOSFAMIDE (eye FOS fa mide) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat testicular cancer and other cancers.
|
|
IFOSFAMIDE (eye FOS fa mide) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat testicular cancer and other cancers.
|
IFOSFAMIDE (eye FOS fa mide) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat testicular cancer and other cancers.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
DEXMEDETOMIDINE (deks MED e toe mi deen) treats agitation due to bipolar disorder or schizophrenia. It works by helping your nervous system calm down.
|
DEXMEDETOMIDINE (deks MED e toe mi deen) treats agitation due to bipolar disorder or schizophrenia. It works by helping your nervous system calm down.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
CANAKINUMAB (can a KIN ue mab) is used to treat certain types of arthritis in children and adults, such as Still's disease. It is also used to treat rare periodic fever syndromes including cryopyrin-associated periodic syndromes (CAPS), tumor necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome (HIDS)/mevalonate kinase deficiency (MKD), and familial Mediterranean fever (FMF). This medicine is not a cure.
|
CANAKINUMAB (can a KIN ue mab) is used to treat certain types of arthritis in children and adults, such as Still's disease. It is also used to treat rare periodic fever syndromes including cryopyrin-associated periodic syndromes (CAPS), tumor necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome (HIDS)/mevalonate kinase deficiency (MKD), and familial Mediterranean fever (FMF). This medicine is not a cure.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
NEPAFENAC (ne paf FEN ak) treats eye pain and inflammation after a procedure. It works by decreasing inflammation in the eye. It belongs to a group of medications called NSAIDs.
|
NEPAFENAC (ne paf FEN ak) treats eye pain and inflammation after a procedure. It works by decreasing inflammation in the eye. It belongs to a group of medications called NSAIDs.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
TILDRAKIZUMAB (til drak iz u mab) is a monoclonal antibody. It is used to treat psoriasis.
|
TILDRAKIZUMAB (til drak iz u mab) is a monoclonal antibody. It is used to treat psoriasis.
|
|